Contribution of protein-protein interactions to the endothelial-barrier-stabilizing function of KRIT1

J Cell Sci. 2022 Jan 15;135(2):jcs258816. doi: 10.1242/jcs.258816. Epub 2022 Jan 25.

Abstract

Krev-interaction trapped protein 1 (KRIT1) is an endothelial scaffold protein that promotes adherens junction (AJ) stability. The precise mechanism by which KRIT1 promotes barrier stabilization is unclear. We tested the ability of a panel of KRIT1 constructs containing mutations that inhibit Rap1 binding, ICAP1α binding, disrupt KRIT1's phosphotyrosine-binding (PTB) domain, or direct KRIT1 to the plasma membrane, either alone or in combination, to restore barrier function in KRIT1-deficient endothelial cells. We found that ablating the 192NPAY195 motif or disrupting the PTB domain was sufficient to restore AJ protein localization and barrier function to control levels, irrespective of the junctional localization of KRIT1 or Rap1 binding. The ability of our KRIT1 constructs to rescue AJ and barrier function in KRIT1-depleted endothelial cells correlated with decreased β1 integrin activity and maintenance of cortical actin fibers. Taken together, our findings indicate that Rap1 binding, ICAP1α binding and junctional localization are not required for the ability of KRIT1 to stabilize endothelial contacts, and suggest that the ability of KRIT1 to limit integrin activity could be involved in barrier stabilization.

Keywords: Adherens junction; Cavernous malformation; Vascular homeostasis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Communication
  • Endothelial Cells*
  • Integrin beta1
  • KRIT1 Protein / genetics
  • Microtubule-Associated Proteins*
  • Proto-Oncogene Proteins

Substances

  • Integrin beta1
  • KRIT1 Protein
  • Microtubule-Associated Proteins
  • Proto-Oncogene Proteins